APGAR DANMARK A/S: Financial statements 2015
CVR: 17533533
Source: annual report 2015, Danish Business Authority
01/07/2014 – 30/06/2015
APGAR DANMARK A/S (CVR 17533533) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 11,800,800 and a net result of DKK 599,474 compared with DKK 3,005,605 the year before. That is a decrease of 17.1% compared with the year before. Equity in the 2015 report amounted to DKK 13,204,810. The solvency ratio was 74.2%.
- Gross Profit
- DKK 11,800,800
- Profit/Loss
- DKK 599,474
- Equity
- DKK 13,204,810
- Total Assets
- DKK 17,792,229
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 11.8 mio. | 599 t. | 13.2 mio. | - |
| 2014 | - | 14.2 mio. | 3 mio. | 15.6 mio. | - |
| 2013 | - | 18.8 mio. | 5.1 mio. | 19.7 mio. | - |
Official annual report
How creditworthy is APGAR DANMARK A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout APGAR DANMARK A/S
APGAR DANMARK A/S is a Danish company of the type Aktieselskab based in Brøndby, founded in 1993. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Christian Markussen and Stig Pieler. The board consists of Christian Markussen, Hanne Pieler, Jan Pedersen and Mette Markussen. The company is owned by PIELER GROUP A/S and MARKUSSEN MEDICAL HOLDING ApS. The company has 13 employees (2018). In 2025, the company reported a gross profit of DKK 12,125,986 and a net result of DKK -1,991,044 compared with DKK 21,676 the year before. Equity in the 2025 report amounted to DKK 10,236,447.